This inventor holds 11 USPTO granted patents and 3 published patent applications. Top assignee: Belhaven Biopharma, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Barry Bleske: Innovator in Pharmaceutical Formulations
Introduction
Barry Bleske is a notable inventor based in Albuquerque, NM (US), recognized for his contributions to pharmaceutical formulations. He holds a total of 11 patents, showcasing his innovative approach to addressing critical medical needs.
Latest Patents
Among his latest patents is the development of dry powder formulations of epinephrine. This invention includes formulations suitable for nasal application, aimed at treating various conditions such as anaphylaxis and respiratory issues. Another significant patent focuses on intranasal compositions for counteracting chemical warfare nerve agents and organophosphate pesticide exposure. These compositions are designed to enhance drug delivery and stability, making them effective in emergency situations.
Career Highlights
Barry Bleske is currently associated with Belhaven Biopharma, Inc., where he continues to advance his research and development efforts. His work emphasizes the importance of creating accessible medical solutions for urgent health crises.
Collaborations
Throughout his career, Barry has collaborated with notable professionals, including Ted William Lanpher and Scott Lyman. These partnerships have contributed to the success of his innovative projects.
Conclusion
Barry Bleske's work in pharmaceutical formulations exemplifies the impact of innovation in medicine. His patents not only address immediate health concerns but also pave the way for future advancements in emergency medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile